Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme - case-control study in breast cancer.

Experimental oncology - 1 Jun 2020

Bialik P, Wysokinski D, Slomka M, Morawiec Z, Strapagiel D, Wozniak K

Abstract excerpt

AIM: UBC9 (E2) small ubiquitin-like modifier conjugating enzyme plays a key role in the post-translational modification of proteins named sumoylation. Defects in small ubiquitin-like modifier modification may contribute to breast carcinogenesis. In the present work, we examined UBC9 genetic variation. MATERIALS AND METHODS: UBC9 genetic variation was analyzed by using the high resolution melting (HRM) method. HRM...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Breast Neoplasms
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Techniques

Share to Haplotypes

Share to Linkage Disequilibrium

Share to Ubiquitin-Conjugating Enzyme UBC9

Share to Ubiquitin-Conjugating Enzymes

Source

Identifiers

PMID: 32602284
DOI: 10.32471/exp-oncology.2312-8852.vol-42-no-2.14739

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme - case-control study in breast cancer.PMID 32602284Read ↗

Polymorphism of UBC9 gene encoding the SUMO-E2-conjugating enzyme and breast cancer risk.Semantic proximity Read ↗

Efficacy of DNA double-strand breaks repair in breast cancer is decreased in carriers of the variant allele of the UBC9 gene c.73G>A polymorphism.Semantic proximity Read ↗

Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.Semantic proximity Read ↗

Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade.Semantic proximity Read ↗

Single-strand conformational polymorphism analysis of a common single nucleotide variation in WRAP53 gene, rs2287499, and evaluating its association in relation to breast cancer risk and prognosis among Iranian-Azeri population.Semantic proximity Read ↗

Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk.Semantic proximity Read ↗

Evaluation of BHMT2 gene expression and its expression factor regulating LNC00922 LNCRNA with rs10944 genotype determination in patients with breast cancerSemantic proximity Read ↗

GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population.Semantic proximity Read ↗

Mutation screening of the RNF8, UBC13 and MMS2 genes in Northern Finnish breast cancer families.Semantic proximity Read ↗

Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissuesSemantic proximity Read ↗

Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: a genetic association study.Semantic proximity Read ↗

Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.